Search

Anish Gupta

Examiner (ID: 8251)

Most Active Art Unit
1654
Art Unit(s)
IPLA, PCTL, 6221, 1811, 1653, 1654
Total Applications
1041
Issued Applications
530
Pending Applications
194
Abandoned Applications
323

Applications

Application numberTitle of the applicationFiling DateStatus
Array ( [id] => 7328472 [patent_doc_number] => 20040253665 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-12-16 [patent_title] => 'Novel peptide-producing enzyme, microbe producing the enzyme and method for dipeptide synthesis using them' [patent_app_type] => new [patent_app_number] => 10/819941 [patent_app_country] => US [patent_app_date] => 2004-04-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 13608 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 40 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0253/20040253665.pdf [firstpage_image] =>[orig_patent_app_number] => 10819941 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/819941
Novel peptide-producing enzyme, microbe producing the enzyme and method for dipeptide synthesis using them Apr 7, 2004 Abandoned
Array ( [id] => 5631011 [patent_doc_number] => 20060147480 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-07-06 [patent_title] => 'Liquid pharmaceutical formulations of fsh and lh together with a non-ionic surfactant' [patent_app_type] => utility [patent_app_number] => 10/551840 [patent_app_country] => US [patent_app_date] => 2004-04-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 14824 [patent_no_of_claims] => 143 [patent_no_of_ind_claims] => 11 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0147/20060147480.pdf [firstpage_image] =>[orig_patent_app_number] => 10551840 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/551840
Liquid pharmaceutical formulations of FSH and LH together with a non-ionic surfactant Apr 1, 2004 Issued
Array ( [id] => 7161604 [patent_doc_number] => 20050084943 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-04-21 [patent_title] => 'New conditions for reactions mediated by yeast' [patent_app_type] => utility [patent_app_number] => 10/814891 [patent_app_country] => US [patent_app_date] => 2004-03-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4576 [patent_no_of_claims] => 34 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0084/20050084943.pdf [firstpage_image] =>[orig_patent_app_number] => 10814891 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/814891
Conditions for reactions mediated by yeast Mar 30, 2004 Issued
Array ( [id] => 7351048 [patent_doc_number] => 20040248769 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-12-09 [patent_title] => 'Enzyme inhibitors for inactivating allergens' [patent_app_type] => new [patent_app_number] => 10/487657 [patent_app_country] => US [patent_app_date] => 2004-02-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4469 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 3 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0248/20040248769.pdf [firstpage_image] =>[orig_patent_app_number] => 10487657 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/487657
Enzyme inhibitors for inactivating allergens Feb 19, 2004 Abandoned
Array ( [id] => 5700615 [patent_doc_number] => 20060217300 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-09-28 [patent_title] => 'Analogues of glp-1' [patent_app_type] => utility [patent_app_number] => 10/546303 [patent_app_country] => US [patent_app_date] => 2004-02-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 25444 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0217/20060217300.pdf [firstpage_image] =>[orig_patent_app_number] => 10546303 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/546303
Analogues of glp-1 Feb 16, 2004 Abandoned
Array ( [id] => 7432204 [patent_doc_number] => 20040162242 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-08-19 [patent_title] => 'Inhibitors of antigen presentation by MHC class II molecules and methods of use thereof' [patent_app_type] => new [patent_app_number] => 10/778756 [patent_app_country] => US [patent_app_date] => 2004-02-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 21221 [patent_no_of_claims] => 25 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0162/20040162242.pdf [firstpage_image] =>[orig_patent_app_number] => 10778756 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/778756
Inhibitors of antigen presentation by MHC class II molecules and methods of use thereof Feb 12, 2004 Issued
Array ( [id] => 7326867 [patent_doc_number] => 20040253226 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-12-16 [patent_title] => 'Compositions and methods for inhibiting endothelial cell proliferation and regulating angiogenesis using serine proteases' [patent_app_type] => new [patent_app_number] => 10/777998 [patent_app_country] => US [patent_app_date] => 2004-02-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 12 [patent_no_of_words] => 15233 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 27 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0253/20040253226.pdf [firstpage_image] =>[orig_patent_app_number] => 10777998 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/777998
Compositions and methods for inhibiting endothelial cell proliferation and regulating angiogenesis using serine proteases Feb 11, 2004 Abandoned
Array ( [id] => 4872705 [patent_doc_number] => 20080199439 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-08-21 [patent_title] => 'IAP-binding cargo molecules and peptidomimetics for use in diagnostic and therapeutic methods' [patent_app_type] => utility [patent_app_number] => 10/777946 [patent_app_country] => US [patent_app_date] => 2004-02-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 9834 [patent_no_of_claims] => 32 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0199/20080199439.pdf [firstpage_image] =>[orig_patent_app_number] => 10777946 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/777946
IAP-binding cargo molecules and peptidomimetics for use in diagnostic and therapeutic methods Feb 10, 2004 Abandoned
Array ( [id] => 74625 [patent_doc_number] => 07750117 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2010-07-06 [patent_title] => 'Methods for heat-stabilizing proteins with specific binding activities' [patent_app_type] => utility [patent_app_number] => 10/777825 [patent_app_country] => US [patent_app_date] => 2004-02-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 3106 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 164 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/750/07750117.pdf [firstpage_image] =>[orig_patent_app_number] => 10777825 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/777825
Methods for heat-stabilizing proteins with specific binding activities Feb 10, 2004 Issued
Array ( [id] => 668519 [patent_doc_number] => 07094760 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2006-08-22 [patent_title] => 'Peptides for treatment of inflammation and shock' [patent_app_type] => utility [patent_app_number] => 10/773229 [patent_app_country] => US [patent_app_date] => 2004-02-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 15 [patent_figures_cnt] => 15 [patent_no_of_words] => 10277 [patent_no_of_claims] => 28 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 124 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/094/07094760.pdf [firstpage_image] =>[orig_patent_app_number] => 10773229 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/773229
Peptides for treatment of inflammation and shock Feb 8, 2004 Issued
Array ( [id] => 7351289 [patent_doc_number] => 20040248808 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-12-09 [patent_title] => 'Methods for preventing mitochondrial permeability transition' [patent_app_type] => new [patent_app_number] => 10/771232 [patent_app_country] => US [patent_app_date] => 2004-02-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 15 [patent_figures_cnt] => 15 [patent_no_of_words] => 11290 [patent_no_of_claims] => 57 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 12 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0248/20040248808.pdf [firstpage_image] =>[orig_patent_app_number] => 10771232 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/771232
Methods for preventing mitochondrial permeability transition Feb 2, 2004 Issued
Array ( [id] => 7155892 [patent_doc_number] => 20050026840 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-02-03 [patent_title] => 'Protein kinase inhibitors comprising ATP mimetics conjugated to peptides or pertidomimetics' [patent_app_type] => utility [patent_app_number] => 10/764288 [patent_app_country] => US [patent_app_date] => 2004-01-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 15369 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0026/20050026840.pdf [firstpage_image] =>[orig_patent_app_number] => 10764288 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/764288
Protein kinase inhibitors comprising ATP mimetics conjugated to peptides or peptidomimetics Jan 22, 2004 Issued
Array ( [id] => 7325042 [patent_doc_number] => 20040138110 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-07-15 [patent_title] => 'Inhibitors of the urokinase receptor' [patent_app_type] => new [patent_app_number] => 10/756289 [patent_app_country] => US [patent_app_date] => 2004-01-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 5414 [patent_no_of_claims] => 33 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 14 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0138/20040138110.pdf [firstpage_image] =>[orig_patent_app_number] => 10756289 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/756289
Inhibitors of the urokinase receptor Jan 13, 2004 Abandoned
Array ( [id] => 6972520 [patent_doc_number] => 20050038230 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-02-17 [patent_title] => 'Linear and cyclic melanocortin receptor-specific peptides' [patent_app_type] => utility [patent_app_number] => 10/756212 [patent_app_country] => US [patent_app_date] => 2004-01-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 12236 [patent_no_of_claims] => 34 [patent_no_of_ind_claims] => 10 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0038/20050038230.pdf [firstpage_image] =>[orig_patent_app_number] => 10756212 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/756212
Linear and cyclic melanocortin receptor-specific peptides Jan 11, 2004 Issued
Array ( [id] => 7424124 [patent_doc_number] => 20040208824 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-10-21 [patent_title] => 'Neutrokine-alpha conjugate, neutrokine-alpha complex, and uses thereof' [patent_app_type] => new [patent_app_number] => 10/742634 [patent_app_country] => US [patent_app_date] => 2003-12-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 61824 [patent_no_of_claims] => 123 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 8 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0208/20040208824.pdf [firstpage_image] =>[orig_patent_app_number] => 10742634 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/742634
Neutrokine-alpha conjugate, neutrokine-alpha complex, and uses thereof Dec 21, 2003 Abandoned
Array ( [id] => 7424124 [patent_doc_number] => 20040208824 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-10-21 [patent_title] => 'Neutrokine-alpha conjugate, neutrokine-alpha complex, and uses thereof' [patent_app_type] => new [patent_app_number] => 10/742634 [patent_app_country] => US [patent_app_date] => 2003-12-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 61824 [patent_no_of_claims] => 123 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 8 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0208/20040208824.pdf [firstpage_image] =>[orig_patent_app_number] => 10742634 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/742634
Neutrokine-alpha conjugate, neutrokine-alpha complex, and uses thereof Dec 21, 2003 Abandoned
Array ( [id] => 679973 [patent_doc_number] => 07084112 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2006-08-01 [patent_title] => 'Activated polyethylene glycol compounds' [patent_app_type] => utility [patent_app_number] => 10/741496 [patent_app_country] => US [patent_app_date] => 2003-12-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 8380 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 7 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/084/07084112.pdf [firstpage_image] =>[orig_patent_app_number] => 10741496 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/741496
Activated polyethylene glycol compounds Dec 18, 2003 Issued
Array ( [id] => 5754607 [patent_doc_number] => 20060223756 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-10-05 [patent_title] => 'Endothelial cell specifically binding peptides' [patent_app_type] => utility [patent_app_number] => 10/537847 [patent_app_country] => US [patent_app_date] => 2003-12-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 23772 [patent_no_of_claims] => 35 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0223/20060223756.pdf [firstpage_image] =>[orig_patent_app_number] => 10537847 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/537847
Endothelial cell specifically binding peptides Dec 16, 2003 Abandoned
Array ( [id] => 7675721 [patent_doc_number] => 20040126397 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-07-01 [patent_title] => 'Use of the neurotoxic component of a botulinum toxin for treating various disorders and conditions and associated pain' [patent_app_type] => new [patent_app_number] => 10/726904 [patent_app_country] => US [patent_app_date] => 2003-12-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5514 [patent_no_of_claims] => 28 [patent_no_of_ind_claims] => 12 [patent_words_short_claim] => 36 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0126/20040126397.pdf [firstpage_image] =>[orig_patent_app_number] => 10726904 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/726904
Use of the neurotoxic component of a botulinum toxin for treating a spastic muscle Dec 1, 2003 Issued
Array ( [id] => 7148106 [patent_doc_number] => 20040170625 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-09-02 [patent_title] => 'Methods of treating Epidermolysis Bullosa and associated dermatological indications with thymosin beta 4, analogues, isoforms and other derivatives' [patent_app_type] => new [patent_app_number] => 10/714405 [patent_app_country] => US [patent_app_date] => 2003-11-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 2746 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 48 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0170/20040170625.pdf [firstpage_image] =>[orig_patent_app_number] => 10714405 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/714405
Methods of treating Epidermolysis Bullosa and associated dermatological indications with thymosin beta 4, analogues, isoforms and other derivatives Nov 16, 2003 Abandoned
Menu